These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1385057)

  • 1. Substance P, vasoactive intestinal polypeptide, and gastrin catabolism in canine liver and kidney.
    Kabemura T; Misawa T; Chijiiwa Y; Nasu T; Nawata H
    Dig Dis Sci; 1992 Nov; 37(11):1661-5. PubMed ID: 1385057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay study of hepatic clearance and disappearance half-time of somatostatin and vasoactive intestinal peptide in dogs.
    Chayvialle JA; Rayford PL; Thompson JC
    Gut; 1981 Sep; 22(9):732-7. PubMed ID: 6117506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nephrectomy on the rate and pattern of the disappearance of exogenous gastrin in dogs.
    Clendinnen BG; Reeder DD; Brandt EN; Thompson JC
    Gut; 1973 Jun; 14(6):462-7. PubMed ID: 4719213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gastrin on circulating levels of somatostatin, pancreatic polypeptide, and vasoactive intestinal peptide in dogs.
    Guzman S; Lonovics J; Chayvialle JA; Hejtmancik KE; Rayford PL; Thompson JC
    Endocrinology; 1980 Jul; 107(1):231-6. PubMed ID: 6103802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of gastrin-52 and gastrin-6 in pigs.
    Hansen CP; Goetze JP; Stadil F; Rehfeld JF
    Am J Physiol Gastrointest Liver Physiol; 2000 Sep; 279(3):G552-60. PubMed ID: 10960354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin infusions increase plasma levels of insulin and VIP but not of gastrin in conscious dogs.
    Stock S; Uvnäs-Moberg K
    Acta Physiol Scand; 1985 Oct; 125(2):205-10. PubMed ID: 3907274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion of progastrin products in human urine.
    Hansen CP; Goetze JP; Stadil F; Rehfeld JF
    Am J Physiol; 1999 Apr; 276(4):G985-92. PubMed ID: 10198343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and organ metabolism of carboxyamidated and glycine-extended gastrins in pigs.
    Hansen CP; Stadil F; Yucun L; Rehfeld JF
    Am J Physiol; 1996 Jul; 271(1 Pt 1):G156-63. PubMed ID: 8760119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of parenteral and enteral nutrition on portal and systemic immunoreactivities of gastrin, glucagon and vasoactive intestinal polypeptide (VIP).
    Gimmon Z; Murphy RF; Chen MH; Nachbauer CA; Fischer JE; Joffe SN
    Ann Surg; 1982 Nov; 196(5):571-5. PubMed ID: 6812513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum peptide profiles in patients with carcinoid tumors.
    Calhoun K; Toth-Fejel S; Cheek J; Pommier R
    Am J Surg; 2003 Jul; 186(1):28-31. PubMed ID: 12842744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of test meal, intragastric nutrients, and intraduodenal bile on plasma concentrations of immunoreactive somatostatin and vasoactive intestinal peptide in dogs.
    Chayvialle JA; Miyata M; Rayford PL; Thompson JC
    Gastroenterology; 1980 Nov; 79(5 Pt 1):844-52. PubMed ID: 6106620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation between pyloric dysmotility and serum levels of gastrin, somatostatin and vasoactive intestinal polypeptide in patients with non-insulin dependent diabetes mellitus].
    Kostic N ; Ratković M; Novaković R; Secen S
    Med Pregl; 1995; 48(5-6):149-51. PubMed ID: 7565332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships of gastrin dose, serum gastrin, and acid secretion.
    McGuigan JE; Isaza J; Landor JH
    Gastroenterology; 1971 Nov; 61(5):659-66. PubMed ID: 5117631
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide.
    Hawley CM; Duggan KA; Macdonald GJ; Shelley S
    Clin Sci (Lond); 1991 Jul; 81(1):79-83. PubMed ID: 1649728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction?
    Basson MD; Fielding LP; Bilchik AJ; Zucker KA; Ballantyne GH; Sussman J; Adrian TE; Modlin IM
    Am J Surg; 1989 Jan; 157(1):109-15. PubMed ID: 2910115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P and vasoactive intestinal polypeptide in the streptozotocin-induced diabetic rat retina.
    Troger J; Neyer S; Heufler C; Huemer H; Schmid E; Griesser U; Kralinger M; Kremser B; Baldissera I; Kieselbach G
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1045-50. PubMed ID: 11274084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secretin and cholecystokinin: hormonal action on the concentration of vasoactive intestinal polypeptide and gastrin in human subjects?].
    Bauer FE; Schulz E; von Kleist D; Janisch HD; Hampel KE
    Z Gastroenterol; 1984 Aug; 22(8):388-93. PubMed ID: 6485438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide inhibition of stimulated gastric secretion. I. Inhibition of meat-stimulated gastric secretion.
    Ebeid AM; Escourrou J; Fischer JE
    Am J Surg; 1980 Jun; 139(6):817-23. PubMed ID: 7386736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin-mediated release of somatostatin and pancreatic polypeptide.
    Guzman S; Lonovics J; Chayvialle JA; Hejtmancik KJ; Rayford PL; Thompson JC
    Surg Forum; 1979; 30():374-6. PubMed ID: 538638
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasoactive intestinal polypeptide-, neurotensin-, substance P-, gastrin-releasing peptide-, calcitonin-, calcitonin gene related peptide-, and somatostatin-like immunoreactivities in human parathyroid glands.
    Weber CJ; O'Dorisio TM; Howe B; D'Agati V; Ward L; Russell J; Feind CR
    Surgery; 1991 Dec; 110(6):1078-85. PubMed ID: 1720902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.